1 Min Read
Jan 6 (Reuters) - Myriad Genetics Inc :
* Myriad Genetics Inc - multiple Blue Cross Blue Shield (bcbs) affiliate plans have issued positive coverage determinations for endopredict Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.